IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

PROIETTI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.444
AS - Asia 6.137
NA - Nord America 5.876
SA - Sud America 902
OC - Oceania 247
AF - Africa 141
Continente sconosciuto - Info sul continente non disponibili 18
Totale 20.765
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.461
CN - Cina 2.436
IT - Italia 1.748
GB - Regno Unito 1.089
SG - Singapore 1.031
DE - Germania 762
RU - Federazione Russa 584
ES - Italia 496
JP - Giappone 474
BR - Brasile 429
IN - India 409
FR - Francia 407
IE - Irlanda 397
SE - Svezia 311
ID - Indonesia 303
NL - Olanda 254
TR - Turchia 232
CA - Canada 230
TW - Taiwan 223
AU - Australia 220
KR - Corea 216
HK - Hong Kong 195
AR - Argentina 158
PL - Polonia 155
MX - Messico 142
CO - Colombia 141
DK - Danimarca 127
BE - Belgio 125
TH - Thailandia 119
AT - Austria 109
PT - Portogallo 98
CH - Svizzera 94
RS - Serbia 93
FI - Finlandia 92
GR - Grecia 89
RO - Romania 85
VN - Vietnam 78
IR - Iran 68
CZ - Repubblica Ceca 65
CL - Cile 59
PK - Pakistan 57
MY - Malesia 45
PH - Filippine 45
IL - Israele 44
PE - Perù 44
EC - Ecuador 40
SA - Arabia Saudita 40
EG - Egitto 34
UA - Ucraina 31
NO - Norvegia 27
NZ - Nuova Zelanda 27
BG - Bulgaria 24
HR - Croazia 23
HU - Ungheria 21
JO - Giordania 20
LT - Lituania 19
SI - Slovenia 18
BY - Bielorussia 17
DZ - Algeria 17
SK - Slovacchia (Repubblica Slovacca) 17
MK - Macedonia 16
BA - Bosnia-Erzegovina 15
MA - Marocco 15
VE - Venezuela 15
EU - Europa 14
KZ - Kazakistan 14
TN - Tunisia 13
ET - Etiopia 11
UZ - Uzbekistan 11
AL - Albania 10
IQ - Iraq 10
UY - Uruguay 10
ZA - Sudafrica 9
EE - Estonia 8
GE - Georgia 8
LV - Lettonia 8
DO - Repubblica Dominicana 7
GT - Guatemala 7
NG - Nigeria 7
BF - Burkina Faso 6
BH - Bahrain 6
CM - Camerun 6
SC - Seychelles 6
AE - Emirati Arabi Uniti 5
BD - Bangladesh 5
HT - Haiti 5
KG - Kirghizistan 5
NP - Nepal 5
CR - Costa Rica 4
HN - Honduras 4
MN - Mongolia 4
MO - Macao, regione amministrativa speciale della Cina 4
AP - ???statistics.table.value.countryCode.AP??? 3
AZ - Azerbaigian 3
BO - Bolivia 3
CI - Costa d'Avorio 3
IS - Islanda 3
JM - Giamaica 3
OM - Oman 3
PY - Paraguay 3
Totale 20.711
Salva come PNG Salva come JPEG
Città #
Singapore 677
Southend 456
Chandler 406
Fairfield 370
Dublin 368
Beijing 348
Princeton 344
Redwood City 295
Milan 277
Council Bluffs 236
Frankfurt am Main 230
Ashburn 229
Houston 224
Wilmington 195
Rome 188
Jakarta 184
Woodbridge 179
Seattle 177
Shanghai 137
Des Moines 132
Taipei 122
Tokyo 121
Cambridge 119
Ann Arbor 112
Bengaluru 111
Santa Clara 106
Istanbul 98
Guangzhou 94
Madrid 93
São Paulo 87
Los Angeles 84
Nanjing 81
Bangkok 76
Liverpool 73
London 65
Buenos Aires 64
Hangzhou 64
Seoul 60
Jinan 59
Belgrade 57
Chengdu 57
Chicago 57
Moscow 56
Bologna 55
Vienna 55
Helsinki 54
New York 54
Eitensheim 53
Hong Kong 52
Bogotá 51
Mumbai 51
Nuremberg 51
Berlin 47
Paris 47
Barcelona 46
San Diego 45
Silver Spring 45
Dearborn 44
Melbourne 42
Toronto 41
Boardman 40
Shenyang 40
Central 39
Changsha 39
Manchester 39
Amsterdam 38
Lima 38
Lisbon 38
Sydney 37
Ho Chi Minh City 35
Phoenix 34
Brussels 33
Santiago 32
Turin 32
Murcia 30
Hefei 29
Montreal 29
Zhengzhou 29
Boston 28
Florence 28
San Jose 28
Athens 27
Glasgow 27
Modena 27
Tianjin 27
Hyderabad 26
Prague 26
Chongqing 25
Hobart 25
Mexico City 25
Naples 25
Yongin-si 25
Ankara 24
Fuzhou 24
Genoa 24
Lappeenranta 24
Warsaw 24
Aarhus 23
Central District 23
Ottawa 23
Totale 9.590
Salva come PNG Salva come JPEG
Nome #
Real-World Use of Apixaban for Stroke Prevention in Atrial Fibrillation : A Systematic Review and Meta-Analysis 1.249
Adherence to oral anticoagulant therapy in patients with atrial fibrillation focus on non-vitamin k antagonist oral anticoagulants 1.189
Adherence to the 'Atrial Fibrillation Better Care' Pathway in Patients with Atrial Fibrillation : Impact on Clinical Outcomes-A Systematic Review and Meta-Analysis of 285,000 Patients 838
Frailty prevalence and impact on outcomes in patients with atrial fibrillation: A systematic review and meta-analysis of 1,187,000 patients 805
Prevalence, management and impact of chronic obstructive pulmonary disease in atrial fibrillation : A systematic review and meta-Analysis of 4,200,000 patients 639
Edoxaban and the Issue of Drug-Drug Interactions: From Pharmacology to Clinical Practice 635
Risk of cardiovascular events in patients with non-alcoholic fatty liver disease: a systematic review and meta-analysis 511
Fatigue in older persons: the role of nutrition 480
Epidemiology and impact of frailty in patients with atrial fibrillation in Europe 468
Long-Term Relationship Between Atrial Fibrillation, Multimorbidity and Oral Anticoagulant Drug Use 395
Contemporary stroke prevention strategies in 11 096 European patients with atrial fibrillation : a report from the EURObservational Research Programme on Atrial Fibrillation (EORP-AF) Long-Term General Registry 393
Inherited and acquired thrombophilia in adults with retinal vascular occlusion : a systematic review and meta-analysis 359
Comparison of HAS-BLED and ORBIT Bleeding Risk Scores in AF Patients treated with NOACs: A Report from the ESC-EHRA EORP-AF General Long-Term Registry 289
'Real-world' atrial fibrillation management in Europe: observations from the 2-year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase 252
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 245
Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non-Vitamin K Antagonist Oral Anticoagulant Trials 237
Update on extended treatment for venous thromboembolism 234
Estimated Absolute Effects on Efficacy and Safety Outcomes of Using Non-Vitamin K Antagonist Oral Anticoagulants in 'Real-World' Atrial Fibrillation Patients : A Comparison With Optimally Acenocoumarol Anticoagulated Patients 232
Relationship between multimorbidity and outcomes in atrial fibrillation 226
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 209
Response of an Italian reference institute to research challenges regarding a new pandemic: COVID-19 network 204
Impact of atrial fibrillation in critically ill patients admitted to a stepdown unit 200
Rate vs. rhythm control and adverse outcomes among European patients with atrial fibrillation 197
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 186
Evaluation of the HAS-BLED, ATRIA and ORBIT bleeding risk scores in atrial fibrillation patients on warfarin 184
Mobile health technology in atrial fibrillation 177
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation : insights from the REPOSI study 169
Describing the relationship between atrial fibrillation and frailty : Clinical implications and open research questions 168
A population screening programme for atrial fibrillation : a report from the Belgian Heart Rhythm Week screening programme 164
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 149
Mobile health technology integrated care in atrial fibrillation patients with diabetes mellitus in China: A subgroup analysis of the mAFA-II cluster randomized clinical trial 148
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 147
Integrated care and outcomes in patients with atrial fibrillation and comorbidities 144
Impact of Liver Disease on Oral Anticoagulant Prescription and Major Adverse Events in Patients with Atrial Fibrillation 142
Estimated stroke risk, yield, and number needed to screen for atrial fibrillation detected through single time screening : a multicountry patient-level meta-analysis of 141,220 screened individuals 137
Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation : the AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management) 132
Compliance of atrial fibrillation treatment with the ABC pathway in patients with concomitant diabetes mellitus in the Middle East based on the Gulf SAFE registry 132
Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry 127
Simple decision-making between a vitamin K antagonist and a non-vitamin K antagonist oral anticoagulant : using the SAMe-TT2R2score 126
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 126
Relation of Nonvalvular Atrial Fibrillation to Body Mass Index (from the SPORTIF Trials) 124
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation 120
Lack of energy is associated with malnutrition in nursing home residents: Results from the INCUR study 119
Impact of rate control in hospitalized patients with atrial fibrillation and sepsis 119
Antidotes to non-vitamin K oral anticoagulants : necessary or not? 118
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension 114
The Sex-Specific Detrimental Effect of Diabetes and Gender-Related Factors on Pre-admission Medication Adherence Among Patients Hospitalized for Ischemic Heart Disease : Insights from EVA Study 113
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 108
Adverse outcomes in patients with atrial fibrillation and peripheral arterial disease : a report from the EURObservational research programme pilot survey on atrial fibrillation 108
Sex-Specific Cut-Offs for High-Sensitivity Cardiac Troponin : Is Less More? 107
COVID-19 in Italy: Ageism and Decision Making in a Pandemic 107
Major Outcomes in Atrial Fibrillation Patients with One Risk Factor : Impact of Time in Therapeutic Range Observations from the SPORTIF Trials 106
Optimizing Stroke and Bleeding Risk Assessment in Patients with Atrial Fibrillation : A Balance of Evidence, Practicality and Precision 105
Antithrombotic treatment strategies after PCI 100
Comprehensive Management With the ABC (Atrial Fibrillation Better Care) Pathway in Clinically Complex Patients With Atrial Fibrillation: A Post Hoc Ancillary Analysis From the AFFIRM Trial 99
Tailored oral anticoagulant prescription in patients with atrial fibrillation : use and misuse of clinical risk prediction scores 99
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy : comment 99
Relationship between low Ankle-Brachial Index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study 98
Atrial Fibrillation and Thromboembolism in Patients With Chronic Kidney Disease 95
Comparison of bleeding risk scores in patients with atrial fibrillation : insights from the RE-LY trial 93
Secondary Versus Primary Stroke Prevention in Atrial Fibrillation : Insights from the Darlington Atrial Fibrillation Registry 90
Frailty: What Is It? 88
Predictors of drug prescription in nursing home residents: results from the INCUR study 84
Usefulness of fibrosis-4 (FIB-4) score and metabolic alterations in the prediction of SARS-CoV-2 severity 82
Use and Prescription of Direct Oral Anticoagulants in Older and Frail Patients with Atrial Fibrillation: A Multidisciplinary Consensus Document 81
Uno studio di registro osservazionale di pazienti geriatrici ospedalizzati in reparti di medicina per acuti: lo studio REGEMA 79
Impact of clinical phenotypes on management and outcomes in European atrial fibrillation patients : a report from the ESC-EHRA EURObservational Research Programme in AF (EORP-AF) General Long-Term Registry 79
Platelet activation is associated with myocardial infarction in patients with pneumonia 78
Chronic Kidney Disease, Time in Therapeutic Range and Adverse Clinical Outcomes in Anticoagulated Patients with Non-valvular Atrial Fibrillation : Observations from the SPORTIF Trials 77
The Compelling Issue of Nonvitamin K Antagonist Oral Anticoagulant Adherence in Atrial Fibrillation Patients : a Systematic Need for New Strategies 75
Optimizing indices of AF susceptibility and burden to evaluate AF severity, risk and outcomes 75
A machine-learning based bio-psycho-social model for the prediction of non-obstructive and obstructive coronary artery disease 73
Use of NOACs in the Peri-Operative Management of Patients with Atrial Fibrillation : To Stop, Bridge or Continue? 72
Pain Management in Nursing Home Residents: Results from the Incur Study 72
Managing thromboembolic risk in patients with subclinical atrial fibrillation: A new challenge for the clinical cardiologist 69
Geriatric Medicine in Italy in the Time of COVID-19 68
Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme : the Belgian Heart Rhythm Week screening programme 67
Clinical phenotype classification of atrial fibrillation patients using cluster analysis and associations with trial-adjudicated outcomes 66
Gender-related determinants of adherence to the mediterranean diet in adults with ischemic heart disease 65
Prevalence of Peripheral Artery Disease by Abnormal Ankle-Brachial Index in Atrial Fibrillation. Implication for Risk and Therapy 65
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for {COVID}-19: comment 65
Comparing outcomes in asymptomatic and symptomatic atrial fibrillation : A systematic review and meta-analysis of 81,462 patients 65
Compliance of Atrial Fibrillation Treatment with the Atrial Fibrillation Better Care (ABC) Pathway Improves the Clinical Outcomes in the Middle East Population: A Report from the Gulf Survey of Atrial Fibrillation Events (SAFE) Registry 64
A comprehensive appraisal of dabigatran etexilate clinical evidence and applications : a 10-year-long story 64
Sex and Gender Differences in Ischemic Heart Disease: Endocrine Vascular Disease Approach (EVA) Study Design 63
Association Between Peripheral Artery Disease and Incident Risk of Atrial Fibrillation : Strong Evidence Coming From Population-Based Cohort Studies 62
The role of hypoxia and inflammation in the regulation of iron metabolism and erythropoiesis in COVID-19: The IRONCOVID study 61
Prevalence of right ventricular dysfunction and impact on all-cause death in hospitalized patients with COVID-19 : a systematic review and meta-analysis 61
Major Bleeding in Patients with Non-Valvular Atrial Fibrillation : Impact of Time in Therapeutic Range on Contemporary Bleeding Risk Scores 60
Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity : insights from the ARISTOTLE trial 60
Stroke Prevention, Evaluation of Bleeding Risk, and Anticoagulant Treatment Management in Atrial Fibrillation Contemporary International Guidelines 60
The Euro Heart Survey and EURObservational Research Programme (EORP) in atrial fibrillation registries : contribution to epidemiology, clinical management and therapy of atrial fibrillation patients over the last 20 years 59
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease 58
Poor nutritional status is associated with fatigue in nursing home residents: a sub-group analysis from the incur study 58
Non-steroidal anti-inflammatory drugs and incident atrial fibrillation 58
Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation 55
Edoxaban in venous thromboembolism and stroke prevention : an appraisal 54
Self-reported physical activity and major adverse events in patients with atrial fibrillation : a report from the EURObservational Research Programme Pilot Survey on Atrial Fibrillation (EORP-AF) General Registry 53
Predicting Bleeding Events in Anticoagulated Patients With Atrial Fibrillation : A Comparison Between the HAS-BLED and GARFIELD-AF Bleeding Scores 53
Nutritional Considerations in Frail Older Patients with COVID-19 53
Totale 17.886
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020134 0 0 0 0 0 0 0 0 0 74 27 33
2020/20213.817 688 234 388 260 340 334 158 350 238 354 185 288
2021/20223.286 176 185 202 233 265 351 210 246 329 251 237 601
2022/20233.841 332 284 249 354 234 486 198 256 356 233 475 384
2023/20245.123 383 413 395 515 775 301 290 313 286 406 501 545
2024/20254.938 396 890 366 480 492 473 424 800 589 28 0 0
Totale 21.705